leisure time -WSS

leisure time

author：comprehensive 2025-09-06 04:34:08 - browse：7

Cambridge: AbbVie — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 — nearly a million dollars more than the company has ever spent in a single quarter. Ruby Wallau for STAT

WASHINGTON — The pharma giant AbbVie spent nearly $4 million on lobbying in the first three months of 2022 alone — more than any other drugmaker spent in the same period, and nearly a million dollars more than the company spent in the same period last year.

AbbVie was the seventh-highest corporate lobbying spender last quarter, ahead of giants like Lockheed Martin, CVS Health, and, AT&T, federal records show.

The number is eye-popping even for the pharmaceutical industry, which is known for its omnipresence on Capitol Hill, and its nearly unlimited lobbying budgets.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Skip the lead apron during X

focus

Wikipedia

WSS

How should state employee insurance handle Wegovy?

Hubble vs. James Webb telescope images: See the difference

There’s no way to know how good AI health technologies are

Medicare to cover more brain scans related to Alzheimer’s drugs

How should state employee insurance handle Wegovy?

'Screen and refer' systems are hurting patients

focus

leisure time

explore

Supreme Court strikes down use of affirmative action

Eight reasons why you should get an updated Covid vaccine

United colonoscopy coverage change 'may cost lives,' doctors say

The biotech scorecard for Q3: 15 stock

United colonoscopy coverage change 'may cost lives,' doctors say

How clinical AI models' predictive power can degrade over time

Jerome Adams on the need for new antivirals for Covid

Penis shrinkage, a side effect of prostate cancer surgery, is temporary

Peter Hotez and the public health issue of online harassment

What the Wegovy shortage looks like for doctors — and for patients

focus

Eight reasons why you should get an updated Covid vaccine

Prescription digital therapeutics are key to pharma’s future

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

Life sciences deals on track to hit lowest point since 2017

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Fatty liver disease was alleviated by Lilly’s ‘triple

focus

explore

Wikipedia

leisure time